See more : Deere & Company (DCO.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Scienture Holdings, Inc. (SCNX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Scienture Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Infortrend Technology, Inc. (2495.TW) Income Statement Analysis – Financial Results
- Kiwetinohk Energy Corp. (KWTEF) Income Statement Analysis – Financial Results
- Golden Century International Holdings Group Limited (0091.HK) Income Statement Analysis – Financial Results
- Arabian International Healthcare Holding Company (9530.SR) Income Statement Analysis – Financial Results
- Metals Creek Resources Corp. (MEK.V) Income Statement Analysis – Financial Results
Scienture Holdings, Inc. (SCNX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.trxadehealth.com
About Scienture Holdings, Inc.
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
Source: https://incomestatements.info
Category: Stock Reports